.svg){kind=small}
Dr Jorg Taubel will be presenting his latest scientific poster presentation on Day 1 from 14h20 to 15h00; Investigating the effect of intravenous APD421 (Amilsulpride) and the ethnic differences between Japanese and Caucasians on cardiac conductionThe theme of this year’s meeting is "Rolling back the frontiers of clinical pharmacology and therapeutics," and its focus will be to revive the spirit of the Society’s founding days and push back the horizons of new clinical pharmacology (and therapeutics) in the 21st century.
-min.jpg)
.jpg)
Latest news
Richmond Appoints Lisa Campbell as Director of Regulatory Strategy
April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read moreVon Willebrand Disease Trial – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol
April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read moreEvents
Swiss Biotech Day 2025
5–6 May 2025
Richmond Pharmacology is pleased to confirm our participation at Swiss Biotech Day 2025
View event
